New evidence-based recommendations released from the Society of Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA) [1] recognize the clinical efficacy of alcohol-based hand wipes and their added benefit as “a convenient option for bed-bound patients, first responders and others who cannot easily get to sinks or wall-mounted dispensers.”[3] The guideline, “Strategies to Prevent Healthcare-Associated Infections through Hand Hygiene,” was featured in the September 2014 issue of the journal Infection Control and Hospital Epidemiology.
PDI, a leader in infection prevention solutions, offers Sani-Hands® Instant Hand Sanitizing Wipes, the No. 1 hand sanitizing wipe in healthcare and the only FDA-approved 70% alcohol-based hand sanitizing wipe following the FDA tentative monograph in the U.S. market.[4] The new recommendations represent a long-awaited update to the 2002 guidelines Guideline for Hand Hygiene in Health-Care Settings from the Centers for Disease Control and Prevention (CDC). In the past ten years, clinical studies have reported alcohol-containing wipe formulations with at least 65% alcohol are comparable to alcohol based handrubs.[5]
“The acknowledgement of the clinical efficacy of alcohol-based wipe delivery systems is a positive change to practice guidelines for hand hygiene that will benefit both healthcare providers as well as patients,” says J. Hudson Garrett Jr., PhD, MSN, MPH, FNP, CSRN, VA-BC, PLNC, vice president of clinical affairs for PDI. “Hand hygiene is identified by the CDC as the No. 1 intervention against the transmission of healthcare-associated infections, and the inclusion of alcohol-based hand wipes in the new SHEA/IDSA Compendium will more make these hand hygiene solutions more broadly available for all healthcare environments, as well as patients.”
The clinical effectiveness of Sani-Hands® wipes has been proven by several independent clinical studies. One study in a stem cell transplant unit demonstrated significant reductions in both MRSA and VRE, and elimination of CRE in the unit. Additionally, patient satisfaction results identified:
• 93% of patients received hand product instruction
• 98% of patients understood how and when to use the alcohol-based hand wipes
• 95% of patients felt their hands were clean after using the alcohol-based hand wipes
• 75% of patients felt they cleaned their hands more often[6]
Sani-Hands® Wipes have been clinically proven to kill 99.99% of germs and bacteria. Available in multiple formats, they are designed to address all hand hygiene needs throughout a facility and help reduce HAIs and associated costs. The Sani-Hands® Instant Hand Sanitizing Wipes Bedside Pack specifically addresses the needs of bed-bound patients by delivering 20 wipes in a simple and convenient re-sealable pack that features intuitive educational “when to use” icons. Unlike gels and foams, the wiping action removes soil from the hands, leaving them feeling clean. The formulation also contains moisturizing aloe to help prevent drying of the skin. To complement its products, PDI delivers a suite of compliance accessories and educational tools for staff, patients and visitors including wall brackets, floor stands and instructional patient education videos.
References:
1. Strategies to Prevent Healthcare-Associated Infections through Hand Hygiene. Infection Control and Hospital Epidemiology, Vol. 35, No. S2, A Compendium of Strategies to Prevent Healthcare-associated Infections in Acute care Hospitals: 2014 Updates (September 2014), pp. S155-S178 http://www.jstor.org/stable/10.1086/677145#rid_rf116
2. GHX Market Intelligence 2014
3. Guideline for Hand Hygiene in Healthcare Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Centers for Disease Control and Prevention. October 25, 2002. http://www.cdc.gov/handhygiene/Guidelines.html
4. Reiner, S; Viall, A; Johnson, K; Walker, A: Enhanced Patient Hand-Hygiene in a Stem Cell Transplant Unit Reduces Multi-Drug Resistant Organism Prevalence, Abstract Presented at the 2013 Association for Professionals in Infection Control and Epidemiology Annual Conference.
Source: PDI
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Resilience and Innovation: The Pivotal Contributions of Black Americans to Health Care and Medicine
February 24th 2025During Black History Month, we honor the resilience and contributions of Black medical professionals in health care. Despite barriers, they have led transformative changes, advocating for equitable access and medical excellence. Recognizing their impact ensures a more inclusive health care future for all.
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.
Infection Intel: GermZapp Is the Innovative Hand Hygiene System IPC Needs
February 14th 2025GermZAPP is an affordable hand hygiene system designed to educate, monitor, and encourage adherence in schools, nursing homes, and health care settings, effectively addressing gaps in infection control.